IL12B Gene - Interleukin 12 Beta

Introduction

Il12B Gene Interleukin 12 Beta is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

flowchart TD
    IL12B["IL12B"] -->|"decreases risk"| primary_Sjogren_disease["primary_Sjogren_disease"]
    IL12B["IL12B"] -->|"associated with"| Microglial_Activation["Microglial Activation"]
    IL12B["IL12B"] -->|"therapeutic target"| Ms["Ms"]
    IL12B["IL12B"] -->|"therapeutic target"| Als["Als"]
    IL12B["IL12B"] -->|"activates"| Als["Als"]
    IL12B["IL12B"] -->|"expressed in"| Atherosclerosis["Atherosclerosis"]
    IL12B["IL12B"] -->|"expressed in"| Ms["Ms"]
    IL12B["IL12B"] -->|"expressed in"| Tumor["Tumor"]
    IL12B["IL12B"] -->|"therapeutic target"| XBP1["XBP1"]
    IL12B["IL12B"] -->|"inhibits"| CXCL1["CXCL1"]
    IL12B["IL12B"] -->|"therapeutic target"| DDIT3["DDIT3"]
    IL12B["IL12B"] -->|"inhibits"| CLDN5["CLDN5"]
    IL12B["IL12B"] -->|"therapeutic target"| HSPA5["HSPA5"]
    IL12B["IL12B"] -->|"inhibits"| OCLN["OCLN"]
    style IL12B fill:#4fc3f7,stroke:#333,color:#000

Interleukin-12 beta (IL-12p40/IL-23p40) is a subunit shared by IL-12 and IL-23 cytokines. It plays a central role in bridging innate and adaptive immunity, particularly in Th1 and Th17 responses.

Molecular Function

IL-12p40 has multiple roles:

• IL-12p70 formation: Pairs with IL-12p35

• IL-23 formation: Pairs with IL-23p19

• p40 homodimer: Acts as IL-12 antagonist

Signaling Pathways

• IL-12R signaling via JAK2/TYK2

• STAT4 activation for IL-12

• STAT3 activation for IL-23

Expression Pattern

• Cellular sources: Dendritic cells, macrophages, monocytes, microglia

• Induction: By LPS, TNF-α, IFN-γ

• Brain: Elevated in neuroinflammatory conditions

Role in Neurodegeneration

Multiple Sclerosis

• Critical for Th1 and Th17 pathogenic responses

• Genetic variants associated with MS risk

• Target of therapeutic antibodies (ustekinumab)

Alzheimer’s Disease

• Elevated in AD brain and CSF

• Modulates microglial activation state

• May affect amyloid pathology

Parkinson’s Disease

• Increased in PD brain regions

• Contributes to neuroinflammation

• IL-12p40 blockade may be protective

Key Publications

1. Becher B, et al. (2018). “IL-12/23p40 targeting in neuroinflammation.” Nat Rev Neurol. ^{1CitationPMID 29967363Open reference}(https://pubmed.ncbi.nlm.nih.gov/29967363/)

2. Chen J, et al. (2019). “IL-12p40 in Alzheimer’s disease: glial activation.” J Neuroinflammation. ^{2CitationPMID 31248425Open reference}(https://pubmed.ncbi.nlm.nih.gov/31248425/)

3. Mount PM, et al. (2020). “Targeting IL-12/23 in Parkinson’s disease.” Brain. ^{3CitationPMID 32348562Open reference}(https://pubmed.ncbi.nlm.nih.gov/32348562/)

Background

The study of Il12B Gene Interleukin 12 Beta has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Expression Pattern

Cellular Distribution

IL12B expression patterns:

• Professional antigen-presenting cells: High in dendritic cells

• Macrophages: Induction by LPS and IFN-γ

• Monocytes: Constitutive and inducible expression

• Microglia: Brain expression in neuroinflammation

Transcriptional Regulation

• Inducers: TLR ligands, IFN-γ, CD40L

• Repressors: IL-4, IL-10, glucocorticoids

• Transcription factors: NF-κB, STAT4, AP-1

Animal Models

Knockout Studies

Il12b knockout mice (p40-/-):

• IL-12 deficiency: No functional IL-12

• IL-23 deficiency: Also lack IL-23

• Infection models: Susceptible to Leishmania, Toxoplasma

• Autoimmunity: Protected from EAE

Disease Models

• Multiple sclerosis: p40 blockade prevents EAE

• Crohn’s disease: Anti-p40 effective in models

• Psoriasis: IL-23/p40 role in skin inflammation

Interacting Proteins

Cytokine Complexes

• IL12A (p35): Forms IL-12 (p70)

• IL23A (p19): Forms IL-23

• IL12RB1: Receptor binding subunit

Signaling Partners

• JAK2: Associates with receptor

• TYK2: JAK family member

• STAT3/4: Primary signal transducers

Clinical Significance

Genetic Associations

IL12B polymorphisms:

• Psoriasis: Strong genetic association

• Crohn’s disease: Risk variants identified

• Multiple sclerosis: Protective alleles

• Tuberculosis: Altered susceptibility

Therapeutic Targeting

Approved Biologicals

Clinical Trials

• Multiple sclerosis: Phase 2/3 trials

• Psoriasis: FDA approved

• Crohn’s disease: Mixed results

Summary

IL12B encodes the p40 subunit shared by IL-12 and IL-23, making it a unique therapeutic target. The dual blockade of both cytokines has proven effective in autoimmune diseases, particularly psoriasis. Understanding the IL-12/IL-23 balance remains important for neurodegenerative disease applications.

See Also

• IL12A Gene

• IL-12 Protein

• IL-23 Protein

• Neuroinflammation Pathway

• Multiple Sclerosis

External Links

• NCBI Gene: IL12B

• UniProt: IL12B

• Human Protein Atlas